BrainsWay Ltd. (BRSYF)
USD 3.4
(0.0%)
USD 3.4
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 471 Thousand USD | -3.48% |
| 2022 | 488 Thousand USD | -35.28% |
| 2021 | 754 Thousand USD | 75.76% |
| 2020 | 429 Thousand USD | 3.62% |
| 2019 | 414 Thousand USD | -85.39% |
| 2018 | 2.83 Million USD | 3.89% |
| 2017 | 2.72 Million USD | 236.67% |
| 2016 | 810 Thousand USD | 537.8% |
| 2015 | 127 Thousand USD | -28.25% |
| 2014 | 177 Thousand USD | 448.0% |
| 2013 | 32.29 Thousand USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 4.36 Million USD | 0.0% |
| 2024 Q1 | 4.48 Million USD | -100.0% |
| 2023 FY | 471 Thousand USD | -3.48% |
| 2023 Q1 | 4.76 Million USD | 876.64% |
| 2023 Q2 | 4.85 Million USD | 1.93% |
| 2023 Q3 | 4.92 Million USD | 1.34% |
| 2023 Q4 | 471 Thousand USD | -90.43% |
| 2022 FY | 488 Thousand USD | -35.28% |
| 2022 Q4 | 488 Thousand USD | 0.0% |
| 2022 Q1 | - USD | -100.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 FY | 754 Thousand USD | 75.76% |
| 2021 Q4 | 754 Thousand USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q4 | 429 Thousand USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 FY | 429 Thousand USD | 3.62% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q1 | 2.86 Million USD | 1.02% |
| 2019 Q2 | - USD | -100.0% |
| 2019 Q4 | 414 Thousand USD | 0.0% |
| 2019 FY | 414 Thousand USD | -85.39% |
| 2018 Q3 | 2.8 Million USD | 0.97% |
| 2018 Q4 | 2.83 Million USD | 0.96% |
| 2018 Q2 | 2.77 Million USD | 0.94% |
| 2018 Q1 | 2.75 Million USD | 0.95% |
| 2018 FY | 2.83 Million USD | 3.89% |
| 2017 Q4 | 2.72 Million USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | 2.72 Million USD | 236.67% |
| 2017 Q1 | - USD | -100.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2016 Q4 | 810 Thousand USD | 0.0% |
| 2016 FY | 810 Thousand USD | 537.8% |
| 2015 Q1 | - USD | -100.0% |
| 2015 FY | 127 Thousand USD | -28.25% |
| 2015 Q4 | 127 Thousand USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q4 | 177 Thousand USD | 0.0% |
| 2014 Q1 | - USD | -100.0% |
| 2014 FY | 177 Thousand USD | 448.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | 32.29 Thousand USD | 0.0% |
| 2013 FY | 32.29 Thousand USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| IR-Med Inc. | 161 Thousand USD | -192.547% |
| BioElectronics Corporation | 14.83 Million USD | 96.824% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -107.487% |
| CVR Medical Corp. | - USD | -Infinity% |
| Össur hf. | 467.73 Million USD | 99.899% |
| Polarean Imaging plc | 216.38 Thousand USD | -117.668% |
| Avitar, Inc. | 5.26 Million USD | 91.055% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -4.787% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | -685.0% |
| Zecotek Photonics Inc. | 3.22 Million USD | 85.381% |
| QHSLab, Inc. | 1.78 Million USD | 73.562% |
| Wellstar International, Inc. | 51.36 Million USD | 99.083% |
| Össur hf. | 467.73 Million USD | 99.899% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 90.974% |
| Escalon Medical Corp. | 524.71 Thousand USD | 10.238% |
| Aurora Spine Corporation | 2.67 Million USD | 82.363% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 3 Million USD | 84.3% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 98.306% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.972% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | 5.117% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -164.437% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | 29.701% |
| Nanomix Corporation | 11.4 Million USD | 95.871% |
| Theraclion SA | 1.95 Million EUR | 75.855% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 4.04 Million USD | 88.347% |
| Positron Corporation | 1.78 Million USD | 73.651% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | 72.27% |
| Lombard Medical, Inc. | 32.29 Million USD | 98.541% |
| ALR Technologies Inc. | 19.26 Million USD | 97.555% |
| Stratec SE | 156.16 Million USD | 99.698% |
| Vycor Medical, Inc. | 1.11 Million USD | 57.577% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -125.052% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -371.0% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -144.176% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 98.526% |
| VMS Rehab Systems, Inc. | 133.52 USD | -352656.141% |
| Guided Therapeutics, Inc. | 2.05 Million USD | 77.114% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | 25.375% |
| Odyssey Group International, Inc. | 2.14 Million USD | 78.038% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | 85.148% |
| Capital Group Holdings, Inc. | 4944.00 USD | -9426.699% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | 41.1% |
| Urologix, Inc. | 5.33 Million USD | 91.168% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 87.705% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 88.826% |
| SS Innovations International, Inc. | 8.21 Million USD | 94.269% |
| Qualis Innovations, Inc. | 9102.00 USD | -5074.687% |
| Smith & Nephew plc | 3.07 Billion USD | 99.985% |
| NIOX Group Plc | 1.4 Million USD | 66.364% |
| Fuse Medical, Inc. | 1.99 Million USD | 76.375% |
| Broncus Holding Corporation | 2.35 Million USD | 79.995% |
| Brain Scientific Inc. | 2.86 Million USD | 83.552% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 97.93% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -1064.631% |